The Role of Exercise in a Weight-Loss Program on Clinical Control in Obese Adults with Asthma A Randomized Controlled Trial

Carregando...
Imagem de Miniatura
Citações na Scopus
169
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER THORACIC SOC
Citação
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, v.195, n.1, p.32-42, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Rationale: Clinical control is difficult to achieve in obese patients with asthma. Bariatric surgery has been recommended for weight loss and to improve asthma control; however, the benefits of nonsurgical interventions have been poorly investigated. Objectives: To examine the effect of exercise training in a weight loss program on asthma control, quality of life, inflammatory biomarkers, and lung function. Methods: Fifty-five obese patients with asthma were randomly assigned to either a weight-loss program plus exercise (WL + E group, n = 28) or a weight-loss program plus sham (WL + S group, n = 27), where the weight-loss program included nutrition (caloric restriction) and psychological therapies. The WL + E group incorporated aerobic and resistance muscle training, whereas the WL + S group incorporated breathing and stretching exercises. Measurements and Main Results: The primary outcome was clinical improvement in asthma control over 3 months. Secondary outcomes included quality of life, lung function, body composition, aerobic capacity, muscle strength, and inflammatory/antiinflammatory biomarkers. After 3 months, 51 patients were analyzed. Compared with the WL + S group, the WL + E group demonstrated improved clinical control scores (median [25th to 75th percentile],-0.7 [-1.3 to -0.3] vs. -0.3 [-0.9 to 0.4]; P = 0.01) and greater weight loss (mean +/- SD, -6.8% +/- 3.5 vs. -3.1% +/- 2.6; P < 0.001) and aerobic capacity (median [25th to 75th percentile], 3.0 [2.4 to 4.0] vs. 0.9 [-0.3 to 1.3] ml O-2 X kg(-1) X min(-1); P < 0.001). These improvements in the WL + E group were also accompanied by improvements in lung function, antiinflammatory biomarkers, and vitamin D levels, as well as reductions in airway and systemic inflammation. Conclusions: Adding exercise to a short-term weight-loss program should be considered as a useful strategy for achieving clinical control of asthma in obese patients.
Palavras-chave
asthma, obesity, exercise training, clinical trial
Referências
  1. Aaron SD, 2004, CHEST, V125, P2046, DOI 10.1378/chest.125.6.2046
  2. Adeniyi FB, 2012, COCHRANE DB SYST REV, V7
  3. ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211
  4. Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC
  5. BRAY GA, 1989, MED CLIN N AM, V73, P161
  6. Charron CB, 2016, CURR OPIN ALLERGY CL, V16, P218, DOI 10.1097/ACI.0000000000000272
  7. de Carvalho-Pinto RM, 2012, RESP MED, V106, P47, DOI 10.1016/j.rmed.2011.08.013
  8. Dias SA, 2014, EUR RESPIR J, V43, P1368, DOI 10.1183/09031936.00053413
  9. Diaz J, 2014, IMMUNOL ALLERGY CLIN, V34, P739, DOI 10.1016/j.iac.2014.07.008
  10. Dixon AE, 2011, J ALLERGY CLIN IMMUN, V128, P508, DOI 10.1016/j.jaci.2011.06.009
  11. Dogra S, 2011, EUR RESPIR J, V37, P318, DOI 10.1183/09031936.00182209
  12. Donnelly JE, 2009, ACSMS GUIDELINES EXE, P226
  13. Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI [10.1164/rccm.9120-11ST, 10.1164/rccm.912011ST]
  14. Fanelli A, 2007, MED SCI SPORT EXER, V39, P1474, DOI 10.1249/mss.0b013e180d099ad
  15. Ford ES, 2005, J ALLERGY CLIN IMMUN, V115, P897, DOI 10.1016/j.jaci.2004.11.050
  16. Franca-Pinto A, 2015, THORAX, V70, P732, DOI 10.1136/thoraxjnl-2014-206070
  17. Freitas PD, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0111-2
  18. Freitas PD, 2015, EUR RESPIR J, V46, pA734
  19. Gibson AL, 2008, AM J CLIN NUTR, V87, P332
  20. Gordon CC, 1988, ANTHROPOMETRIC STAND, P3
  21. Hoeger W.W.K., 1990, J APPL SPORT SCI RES, V4, P47
  22. Jiao JF, 2015, CURR OPIN ALLERGY CL, V15, P375, DOI 10.1097/ACI.0000000000000187
  23. Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012
  24. JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1
  25. JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76
  26. Juniper EF, 2001, AM J RESP CRIT CAR 2, V163
  27. KEENAN NL, 1992, AM J EPIDEMIOL, V135, P678
  28. Laquatra I., 2000, KRAUSS FOOD NUTR DIE, P485
  29. Ma Jun, 2015, Ann Am Thorac Soc, V12, P1, DOI 10.1513/AnnalsATS.201406-271OC
  30. Mendes FAR, 2010, CHEST, V138, P331, DOI 10.1378/chest.09-2389
  31. Miller MR, 2005, FUR RESP J, V26, P319, DOI 10.1183/09031936.05.00034805
  32. Neder JA, 1999, THORAX, V54, P202
  33. NHLBI, 2013, PRACT GUID ID EV TRE
  34. Nickel T, 2011, MEDIAT INFLAMM, DOI 10.1155/2011/308965
  35. Global Initiative for Asthma, 2015, GLOB STRAT ASTHM MAN
  36. Nimmo MA, 2013, DIABETES OBES METAB, V15, P51, DOI 10.1111/dom.12156
  37. Olivo CR, 2012, RESP PHYSIOL NEUROBI, V182, P81, DOI 10.1016/j.resp.2012.05.004
  38. Pakhale S, 2015, CHEST, V147, P1582, DOI 10.1378/chest.14-3105
  39. Pastva A, 2004, J IMMUNOL, V172, P4520
  40. Peters-Golden M, 2006, EUR RESPIR J, V27, P495, DOI 10.1183/09031936.06.00077205
  41. PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390
  42. Reddy RC, 2011, OBES SURG, V21, P200, DOI 10.1007/s11695-010-0155-6
  43. Mendes FAR, 2011, MED SCI SPORT EXER, V43, P197, DOI 10.1249/MSS.0b013e3181ed0ea3
  44. Scott HA, 2013, CLIN EXP ALLERGY, V43, P36, DOI 10.1111/cea.12004
  45. Silva RA, 2010, EUR RESPIR J, V35, P994, DOI 10.1183/09031936.00049509
  46. Tudor-Locke C, 2004, SPORTS MED, V34, P1
  47. Tzotzas T, 2010, J CLIN ENDOCR METAB, V95, P4251, DOI 10.1210/jc.2010-0757
  48. van Huisstede A, 2015, THORAX, V70, P659, DOI 10.1136/thoraxjnl-2014-206712
  49. Vieira RP, 2007, AM J RESP CRIT CARE, V176, P871, DOI 10.1164/rccm.200610-1567OC
  50. Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005